Centogene receives Nasdaq notice of delisting, will request hearing

Centogene that the company received a staff determination letter on Feb. 27, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market notifying the company of the determination of the Nasdaq staff to delist the company’s securities from The Nasdaq Global Market due to non-compliance with the minimum $15M Market Value of Publicly Held Shares requirement as set forth in Nasdaq Listing Rule 5450(b)(2)(C). The Staff Determination has no immediate effect and will not immediately result in the suspension of trading or delisting of the company’s securities. The Letter stated that unless the company timely requests a hearing before a Hearings Panel, the company would be subject to delisting. Accordingly, the company intends to timely request a hearing before the Panel. The hearing request will automatically stay any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Panel following the hearing.